Quasi Medicine Registration

Indonesia has introduced a new regulatory category for quasi-medical products, which bridges the gap between consumer goods and medicinal products. Our quasi medicine registration service supports international manufacturers in classifying, registering, and legally marketing quasi medicine products in Indonesia in line with the latest BPOM regulatory framework.

Seamless Compliance Support

End-to-End Service

We manage the full regulatory pathway from licensing to product registration.

Regulatory Expertise

Our team combines deep knowledge and experience to navigate complex regulatory landscapes.

Speed and Efficiency

Our proven strategies accelerate the registration and approval process for the Indonesian market.

Customized Support

Provide personalized guidance and dedicated support to ensure a smooth, worry-free journey.

Why Choose Our Quasi Medicine Registration?

Indonesia’s Food and Drug Authority (BPOM) has introduced stricter supervision for traditional medicines, quasi medicines, and health supplements, redefining how certain products must be classified and registered. Products that were previously classified as cosmetics or consumer goods may now be categorized as quasi-medicines, triggering new regulatory obligations.

Our service helps international manufacturers navigate this evolving framework by providing clear regulatory positioning, documentation strategy, and BPOM submission support. We reduce the risk of misclassification, enforcement action, or forced product withdrawal by ensuring your product is registered under the correct category from the start.

This service is especially critical for products with:

  • Functional or preventive claims
  • Pharmacological or bioactive ingredients
  • Borderline positioning between cosmetics, supplements, and medicines

Scope and Benefits of Our Service

Structured quasi-drug registration in Indonesia supports compliant market entry.

Product Classification & Regulatory Positioning

We support the setup and approval of licensed medical device distributors in compliance with MoH requirements.

Dossier Preparation & Submission Support

Preparation of technical documentation, labeling review, and structured BPOM submission for quasi-drug products.

Regulatory Liaison & Approval Management

Coordination with BPOM during evaluation, clarification handling, and approval monitoring to reduce delays.

Market Entry Support

Flexible market entry options supporting IVD and medical product registration for international manufacturers entering Indonesia.

License Holder Service

For manufacturers without a local entity, we act as a neutral license holder, keeping registrations secure and transferable.

Distributor Selection

We assist in identifying and assessing qualified local distributors aligned with regulatory and commercial requirements.

Undername Service

We enable faster market entry by registering products under an approved local structure without immediate company setup.

Company Registration Support

When you are ready to establish a local presence, we assist with compliant company formation in Indonesia.

Inquiry Form

Our team is prepared to discuss your business needs and address any questions you may have. Fill out our inquiry form, and we’ll respond within one business day.

Contact Form
Submit with your company email for quicker response and priority handling.

Other ways to get in touch with us.

 Frequently Asked Questions (FAQ)

Quasi medicine refers to products that are not classified as prescription or over-the-counter drugs, but contain active substances or claims that go beyond cosmetics or general consumer goods. These products require closer regulatory supervision due to their functional or health-related effects.
BPOM introduced this framework to improve consumer protection and ensure products with pharmacological or functional effects are properly evaluated. Businesses were given a transition period to comply with the new classification and registration requirements.
Yes. Quasi-drug products must be registered with BPOM before importation and distribution in Indonesia. Products that are incorrectly classified or unregistered may be blocked at customs or withdrawn from the market.
Examples may include medicated personal care products, antiseptic or therapeutic topical products, functional hygiene products, and other items with active ingredients or health-related claims that exceed cosmetic scope.
Quasi-medical products often sit between cosmetics, health supplements, and medicines. Unlike cosmetics, they may have preventive or functional claims. Unlike supplements, they may be applied externally or have localized effects. Correct classification is essential to determine the applicable registration pathway.
Typical requirements include product formulation details, safety and efficacy data, labeling and claims review, manufacturing information, and supporting technical documentation. The exact scope depends on the product risk level and intended use.

Yes. BPOM may reclassify a product if it determines that claims or ingredients fall outside the initially proposed category.
We help manage this risk through early regulatory assessment and positioning strategy.

Yes, but only if the registration structure allows it. Using a neutral license holder ensures flexibility, allowing manufacturers to change distributors without losing their product approvals.
Quasi-drug is a complex and evolving category. We combine regulatory expertise, BPOM engagement experience, and market-entry strategy to help international manufacturers register products compliantly and protect long-term market access in Indonesia.

Strategic Leadership with
Dr. Hussein H. Mashhour, MD

As our Chief Operating Officer (COO), Dr. Hussein H. Mashhour, MD, brings over a decade of dedicated, hands-on experience in product registration and licensing across Indonesia’s most complex regulatory sectors. His strategic oversight ensures that our operational procedures and client services are built on proven, efficient processes. Start your journey with the confidence and clarity only an expert leader in both compliance and operations can provide.

Explore latest Insight
Common Halal Certification Mistakes Every Exporter Should Avoid
Halal Certification for Supplement Products in Indonesia: Before You Register with BPOM
Why U.S. Food Supplement Companies Need Halal Certification in Indonesia
Common Halal Certification Mistakes Every Exporter Should Avoid
Halal Certification for Supplement Products in Indonesia: Before You Register with BPOM
Common Halal Certification Mistakes Every Exporter Should Avoid